Pharmaceutical Research

, Volume 15, Issue 6, pp 889–896 | Cite as

In Vitro Dissolution Profile Comparison—Statistics and Analysis of the Similarity Factor, f2

  • Vinod P. Shah
  • Yi Tsong
  • Pradeep Sathe
  • Jen-Pei Liu

Abstract

Purpose. To describe the properties of the similarity factor (f2) as a measure for assessing the similarity of two dissolution profiles. Discuss the statistical properties of the estimate based on sample means.

Methods. The f2 metrics and the decision rule is evaluated using examples of dissolution profiles. The confidence interval is calculated using bootstrapping method. The bias of the estimate using sample mean dissolution is evaluated.

Results. 1. f2 values were found to be sensitive to number of sample points, after the dissolution plateau has been reached. 2. The statistical evaluation of f2 could be made using 90% confidence interval approach. 3. The statistical distribution of f2 metrics could be simulated using 'Bootstrap' method. A relatively robust distribution could be obtained after more than 500 'Bootstraps'. 4. A statistical 'bias correction' was found to reduce the bias.

Conclusions. The similarity factor f2 is a simple measure for the comparison of two dissolution profiles. But the commonly used similarity factor estimate ^f2 is a biased and conservative estimate of f2. The bootstrap approach is a useful tool to simulate the confidence interval.

dissolution similarity factor estimation bias bootstrap confidence interval 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. 1.
    FDA Guidance for Industry: Immediate Release Solid Dosage Forms: Scale-up and Post Approval Changes (SUPAC-IR): Chemistry, Manufacturing and Controls, In Vitro Dissolution Testing and In Vivo Bioequivalence Documentation, November, 1995.Google Scholar
  2. 2.
    FDA Guidance for Industry: Dissolution Testing of Immediate Release Solid Oral Dosage Forms, August, 1997.Google Scholar
  3. 3.
    FDA Guidance for Industry: Extended Release Oral Dosage Forms: Development, Evaluation and Application of In Vitro/In Vivo Correlations, September, 1997.Google Scholar
  4. 4.
    FDA Guidance for Industry: Modified Release Solid Oral Dosage Forms: Scale-Up and Post Approval Changes (SUPAC-MR): Chemistry, Manufacturing and Controls; In Vitro Dissolution Testing and In Vivo Bioequivalence Documentation, September, 1997.Google Scholar
  5. 5.
    V. P. Shah, L. A. Yamamoto, D. Shuirmann, J. Elkins, and J. P. Skelly. Analysis of in vitro dissolution of whole versus half controlled release theophylline tablets. Pharm. Res. 4:416-419 (1987).Google Scholar
  6. 6.
    S. C. Chow and F. Y. C. Ki. Statistical comparison between dissolution profiles of drug products. J. Biopharm. Stat. 7:241-258 (1997).Google Scholar
  7. 7.
    P. Sathe, Y. Tsong, and V. P. Shah. In-vitro dissolution profile comparison: statistics and analysis, model dependent approach. Pharm. Res. 13:1799-1803 (1996).Google Scholar
  8. 8.
    Y. Tsong, T. Hammerstrom, P. Sathe, and V. P. Shah. Statistical assessment of mean difference between two dissolution data sets. Drug Inf. J. 30:1105-1112 (1996).Google Scholar
  9. 9.
    J. W. Moore and H. H. Flanner. Mathematical comparison of curves with an emphasis on in-vitro dissolution profiles. Pharm. Tech. 20(6):64-74 (1996).Google Scholar
  10. 10.
    J. E. Polli, G. S. Rekhi, and V. P. Shah. Methods to compare dissolution profiles. Drug Info. J. 30:1113-1120 (1996).Google Scholar
  11. 11.
    J. E. Polli, G. S. Rekhi, L. L. Augsburger, and V. P. Shah. Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets. J. Pharm. Sci. 86:690-700 (1997).Google Scholar
  12. 12.
    J. P. Liu, M. C. Ma, and S. C. Chow. Statistical evaluation of similarity factor f2 as a criterion for assessment of similarity between dissolution profiles. Drug Info. J. 31:1255-1271 (1997).Google Scholar
  13. 13.
    H. L. Ju and Liaw S. On the assessment of similarity of drug dissolution profile—a simulation study. Drug Info. J. 31:1273-1289 (1997).Google Scholar
  14. 14.
    R. A. Johnson and D. W. Wichern. Applied Multivariate Statistical Analysis, Prentice-Hall, Inc. Englewood Cliffs, NJ, 1982.Google Scholar
  15. 15.
    Y. Tsong, P. Sathe, and V. P. Shah. Comparing two dissolution data sets for similarity, American Statistical Association. 1996 Proceedings of the Biopharmaceutical Section, 129-134, 1997.Google Scholar
  16. 16.
    B. Efron and R. J. Tibshirani. An Introduction to the Bootstrap, Chapman & Hall, New York, NY, 1993.Google Scholar

Copyright information

© Plenum Publishing Corporation 1998

Authors and Affiliations

  • Vinod P. Shah
    • 1
  • Yi Tsong
    • 2
  • Pradeep Sathe
    • 1
  • Jen-Pei Liu
    • 3
  1. 1.Office of Pharmaceutical Science, Center for Drug Evaluation and Research, Food and Drug AdministrationRockville
  2. 2.Division of Biometrics III, Office of Epidemiology and Biometrics, Center for Drug Evaluation and Research, Food and Drug AdministrationRockville
  3. 3.Department of StatisticsNational Cheng-Kung UniversityTainan, TaiwanROC

Personalised recommendations